Sanofi-Aventis SAR650894 Program - Research Component

-
Investigator: Thomas G. Martin, MD
Sponsor: Sanofi-Aventis Group

Location(s): United States

Description

Testing a CD38-targeting antibody that has demonstrated anticancer activity in preclinical testing and does not have a separate cytotoxic agent attached. For the treatment of certain hematological malignancies.